Please login to the form below

Not currently logged in
Email:
Password:

Scotland

This page shows the latest Scotland news and features for those working in and with pharma, biotech and healthcare.

SMC enables access to Kyowa Kirin’s Crysvita for rare bone disease

SMC enables access to Kyowa Kirin’s Crysvita for rare bone disease

Under this framework, eligible children in Scotland will be able to access Crysvita while Kyowa Kirin collects additional data, to address any areas of uncertainty. ... After three years, the SMC will review the new evidence and make a final decision on

Latest news

More from news
Approximately 7 fully matching, plus 228 partially matching documents found.

Latest Intelligence

  • Creativity in storytelling: why pharma must invest more in creativity Creativity in storytelling: why pharma must invest more in creativity

    Guy Vickerstaff, Chair of IPA Scotland, said: “For all the data, for all the latest tech, for all the influencers and all the noise, it’s all too easy to lose

  • The UK’s new medicines pricing deal – opportunities and risks for pharma The UK’s new medicines pricing deal – opportunities and risks for pharma

    Different from the 2014 PPRS is the requirement for companies to offer the same deal – whether agreed in England, Scotland, Wales or Northern Ireland – across all nations.

  • The Orkambi row explained The Orkambi row explained

    May 2016: Orkambi and Kalydeco rejected in Scotland. June 2016: NICE gives final rejection of Orkambi in England – the Cystic Fibrosis Trust suggests a solution using the UK CF Registry to

  • The Orkambi blame game The Orkambi blame game

    Leiden added: “It could be the same price as Scotland. That’s the quickest way.”. ... Deciphering the feasibility of this hope was difficult for the MPs, as Scotland’s deal with Vertex remains confidential.

  • #OrkambiNow? #OrkambiNow?

    A market access deal with Scotland’s government has provided new impetus to the talks in England, with the hope that both sides can climb down and reach agreement soon.

More from intelligence
Approximately 0 fully matching, plus 18 partially matching documents found.

Latest appointments

More from appointments
Approximately 2 fully matching, plus 4 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 22 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Creative Medical Research

Specialising in medical device market research and participant recruitment human factors research, our approach is people-centric. We thrive on making...

Latest intelligence

Ludovic Helfgott
Novo Nordisk awakens its ‘Sleeping Beauty’
Biopharm emerges from troubled times to hit ‘solid growth’, says executive vice president Ludovic Helfgott...
How will the Tories’ historic win shape the NHS?
Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore the impact of December’s General Election result on 2020 and beyond...
CSR 'Christmas Spirit' 2019
OPEN Health champions CSR over Christmas by giving back to the community and increasing our activities and efforts...

Infographics